Search

everythinglearnresearchcommunity

for

Search:↓

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

ILC1 cells contribute to hair loss in alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Hair follicles prevent NK cell attacks to avoid hair loss.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

ALRN-6924 may prevent hair loss caused by chemotherapy.

NK cells play a role in skin diseases like eczema and psoriasis.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Stress may trigger hair loss by affecting immune protection in hair follicles.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.